| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1085 | 2022 |
| Orchestrating single-cell analysis with Bioconductor RA Amezquita, ATL Lun, E Becht, VJ Carey, LN Carpp, L Geistlinger, ... Nature methods 17 (2), 137-145, 2020 | 794 | 2020 |
| A role for the actin cytoskeleton in cell death and aging in yeast CW Gourlay, LN Carpp, P Timpson, SJ Winder, KR Ayscough The Journal of cell biology 164 (6), 803-809, 2004 | 354 | 2004 |
| The Sec1p/Munc18 protein Vps45p binds its cognate SNARE proteins via two distinct modes LN Carpp, LF Ciufo, SG Shanks, A Boyd, NJ Bryant The Journal of cell biology 173 (6), 927-936, 2006 | 121 | 2006 |
| Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials DV Mehrotra, HE Janes, TR Fleming, PW Annunziato, KM Neuzil, ... Annals of internal medicine 174 (2), 221-228, 2021 | 120 | 2021 |
| Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America Z Moodie, M Juraska, Y Huang, Y Zhuang, Y Fong, LN Carpp, SG Self, ... The Journal of infectious diseases 217 (5), 742-753, 2018 | 104 | 2018 |
| A meta-analysis of passive immunization studies shows that serum-neutralizing antibody titer associates with protection against SHIV challenge A Pegu, B Borate, Y Huang, MG Pauthner, AJ Hessell, B Julg, ... Cell host & microbe 26 (3), 336-346. e3, 2019 | 93 | 2019 |
| Single-cell immunology of SARS-CoV-2 infection Y Tian, LN Carpp, HER Miller, M Zager, EW Newell, R Gottardo Nature biotechnology 40 (1), 30-41, 2022 | 92 | 2022 |
| Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ... Nature communications 14 (1), 331, 2023 | 80 | 2023 |
| Immune correlates analysis of the ENSEMBLE single Ad26. COV2. S dose vaccine efficacy clinical trial Y Fong, AB McDermott, D Benkeser, S Roels, DJ Stieh, A Vandebosch, ... Nature microbiology 7 (12), 1996-2010, 2022 | 78 | 2022 |
| Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition PB Gilbert, Y Huang, AC deCamp, S Karuna, Y Zhang, CA Magaret, ... Nature Medicine 28 (9), 1924-1932, 2022 | 76 | 2022 |
| Immune Assays Team § ; Moderna, Inc. Team § ; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team § ; United States Government (USG)/CoVPN … PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 70 | 2022 |
| Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials M Juraska, CA Magaret, J Shao, LN Carpp, AJ Fiore-Gartland, ... Proceedings of the National Academy of Sciences 115 (36), E8378-E8387, 2018 | 67 | 2018 |
| Homotypic vacuole fusion in yeast requires organelle acidification and not the V-ATPase membrane domain EM Coonrod, LA Graham, LN Carpp, TM Carr, L Stirrat, K Bowers, ... Developmental cell 27 (4), 462-468, 2013 | 67 | 2013 |
| Quantitative proteomic analysis of host-virus interactions reveals a role for Golgi brefeldin A resistance factor 1 (GBF1) in dengue infection LN Carpp, RS Rogers, RL Moritz, JD Aitchison Molecular & Cellular Proteomics 13 (11), 2836-2854, 2014 | 57 | 2014 |
| Interaction between the yellow fever virus nonstructural protein NS3 and the host protein Alix contributes to the release of infectious particles LN Carpp, R Galler, MC Bonaldo Microbes and infection 13 (1), 85-95, 2011 | 57 | 2011 |
| Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation Y Huang, O Borisov, JJ Kee, LN Carpp, T Wrin, S Cai, M Sarzotti-Kelsoe, ... Scientific reports 11 (1), 23921, 2021 | 56 | 2021 |
| A systems vaccinology approach reveals temporal transcriptomic changes of immune responses to the yellow fever 17D vaccine J Hou, S Wang, M Jia, D Li, Y Liu, Z Li, H Zhu, H Xu, M Sun, L Lu, Z Zhou, ... The Journal of Immunology 199 (4), 1476-1489, 2017 | 47 | 2017 |
| Modification of the association between T-cell immune responses and human immunodeficiency virus type 1 infection risk by vaccine-induced antibody responses in the HVTN 505 trial Y Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ... The Journal of infectious diseases 217 (8), 1280-1288, 2018 | 45 | 2018 |
| HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy PB Gilbert, Y Fong, M Juraska, LN Carpp, AS Monto, ET Martin, JG Petrie BMC infectious diseases 19, 1-12, 2019 | 39 | 2019 |
Peter B. GilbertMember, Fred Hutchinson Cancer Center, and Department of Biostatistics, University of WashingtonBestätigte E-Mail-Adresse bei scharp.org